SynopsisThe global Organ Preservation Solutions market size is expected to reach US$ 246.5 million by 2029, growing at a CAGR of 9.7% from 2023 to 2029. The market is mainly driven by the significant applications of Organ Preservation Solutions in various end use indu.....
SynopsisPlaque modification devices clear out the blockage in the arteries, helping them regain their normal function resulting in improved blood circulation and heart function. Plaque in the arteries is a deposition of fat on the walls of arteries, that narrow the ar.....
SynopsisTear duct occluder is a small medical device designed to block or occlude the tear duct openings (puncta) in the eyelid. It is used to treat conditions such as dry eye syndrome by reducing tear drainage and increasing moisture retention on the ocular surface. .....
SynopsisGlobal Hysterosalpingography Catheter market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War.....
SynopsisMicroelectronic medical implant is any sort of medical device that involves microelectronic components and is placed inside the body of the patient to achieve the desired physiological response. The microelectronic medical implants market has come a long way s.....
SynopsisThe global CT Contrast Injectors market size is expected to reach US$ 2038.9 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of CT Contrast Injectors in various end use industries. The e.....
SynopsisThe global Neonatal & Preterm Infant Enteral Feeding Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Neonatal & Prete.....
SynopsisFabrazyme® (agalsidase beta) is used to treat patients with Fabry disease. Fabrazyme lowers the amount of a substance called globotriaosylceramide (GL-3), which builds up in cells lining the blood vessels of the kidney and certain other cells. The global.....
SynopsisGlobal Chronic Hepatitis B Drugs market is projected to reach US$ million in 2030, increasing from US$ million in 2023, with the CAGR of % during the period of 2024 to 2030. Key companies engaged in the Chronic Hepatitis B Drugs industry include GSK, Bri.....
SynopsisThe global Bariatric Manual Wheelchair market was valued at US$ 206 million in 2023 and is anticipated to reach US$ 272.8 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030. Illness in older populations often co-occurs with o.....
